Novel opportunities in the treatment and prevention of scarring

Journal of Cutaneous Medicine and Surgery

Volumn 8, Issue SUPPL. 3, 2004, Pages 32-36

  Berman, Brian ^a,b   Villa, Adriana M ^a   Ramirez, Claudia C ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b Dept Dermatol and Cutaneous Surg ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ALPHA2B INTERFERON; ANGIOTENSIN DERIVATIVE; ANGIOTENSIN[1-7][3 NORLEUCINE]; BLEOMYCIN; BOTULINUM TOXIN A; CELECOXIB; FLUOROURACIL; GAMMA INTERFERON; IMIQUIMOD; OLIGODEOXYNUCLEOTIDE PHOSPHOROTHIOATE; TACROLIMUS; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; UNCLASSIFIED DRUG; VERAPAMIL;

ARTICLE; ATOPIC DERMATITIS; CARBON DIOXIDE LASER; CLINICAL TRIAL; ERBIUM YAG LASER; HUMAN; HYPERPIGMENTATION; HYPERTROPHIC SCAR; INFECTION; ISCHEMIA; KELOID; NONHUMAN; PIGMENT DISORDER; PRIORITY JOURNAL; PULSED DYE LASER; PURPURA; SCAR FORMATION; SKIN ATROPHY; SKIN BURNING SENSATION; SKIN NECROSIS; SKIN SCAR; TELANGIECTASIA; THROMBOSIS;

BLEOMYCIN; BOTULINUM TOXIN TYPE A; CICATRIX; FLUOROURACIL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LASER SURGERY; NEUROMUSCULAR AGENTS; PYRAZOLES; SULFONAMIDES; TACROLIMUS; VERAPAMIL;

EID: 18844416390     PISSN: 12034754     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10227-004-0806-0     Document Type: Article

References (54)

1. JC Murray 1993 Scars and keloids Dermatol Clin 11 697 708
2. RS English PD Shenefelt 1999 Keloids and hypertrophic scars Dermatol Surg 25 631 638
3. GJ Goodman 2000 Postacne scarring: a review of its pathophysiology and treatment Dermatol Surg 26 857 871
4. M Yokozeki Y Baba H Shimokawa 1999 Interferon-gamma inhibits the myofibroblastic phenotype of rat palatal fibroblasts induced by transforming growth factor-beta1 in vitro FEBS Lett 442 61 64
5. B Nedelec YJ Shen A Ghahary 1995 The effect of interferon alpha 2b on the expression of cytoskeletal proteins in an in vitro model of wound contraction J Lab Clin Med 126 474 484
6. B Berman MR Duncan 1989 Short-term keloid treatment in vivo with human interferon alfa-2b results in a selective and persistent normalization of keloidal fibroblast collagen, glycosaminoglycan, and collagenase production in vitro J Am Acad Dermatol 21 694 702
7. B Berman F Flores 1997 Recurrence rates of excised keloids treated with postoperative triamcinolone acetonide injections or interferon alfa-2b injections J Am Acad Dermatol 37 755 757
8. SE Jacob B Berman M Nassiri 2003 Topical application of imiquimod 5% cream to keloids alters expression genes associated with apoptosis Br J Dermatol 149 (suppl 66) suppl 66 62 65
9. B Berman J Kaufman 2002 Pilot study of the effect of postoperative imiquimod 5% cream on the recurrence rate of excised keloids J Am Acad Dermatol 47 S209 S211
10. A Kim J DiCarlo C Cohen 2001 Are keloids really "gli-loids"? High-level expression of gli-1 oncogene in keloids J Am Acad Dermatol 45 707 711
11. DA Ladin Z Hou D Patel 1998 p53 and apoptosis alterations in keloids and keloid fibroblasts Wound Repair Regen 6 28 37
12. ID Louro P McKie-Bell H Gosnell 1999 The zinc finger protein GLI induces cellular sensitivity to the mTOR inhibitor rapamycin Cell Growth Differ 10 503 516
13. TS Alster CM Williams 1995 Treatment of keloid sternotomy scars with 585 nm flashlamp-pumped pulsed-dye laser Lancet 345 1198 1200
14. MP Goldman RE Fitzpatrick 1995 Laser treatment of scars Dermatol Surg 21 685 687
15. SR Reiken SF Wolfort F Berthiaume 1997 Control of hypertrophic scar growth using selective photothermolysis Lasers Surg Med 21 7 12
16. JB McCraw JA McCraw A McMellin 1999 Prevention of unfavorable scars using early pulse dye laser treatments: a preliminary report Ann Plast Surg 42 7 14
17. K Nouri GP Jimenez C Harrison-Balestra 2003 585-nm pulsed dye laser in the treatment of surgical scars starting on the suture removal day Dermatol Surg 29 65 73
18. JR Lupton TS Alster 2002 Laser scar revision Dermatol Clin 20 55 65
19. LE Bowes K Nouri B Berman 2002 Treatment of pigmented hypertrophic scars with the 585 nm pulsed dye laser and the 532 nm frequency-doubled Nd:YAG laser in the Q-switched and variable pulse modes: a comparative study Dermatol Surg 28 714 719
20. AS Rogachefsky M Hussain DJ Goldberg 2003 Atrophic and a mixed pattern of acne scars improved with a 1320-nm Nd:YAG laser Dermatol Surg 29 904 908
21. TS Alster TB West 1996 Resurfacing of atrophic facial acne scars with a high-energy, pulsed carbon dioxide laser Dermatol Surg 22 151 154
22. 2 laser resurfacing of atrophic acne scars Dermatol Surg 25 926 930
23. C Ho Q Nguyen NJ Lowe 1995 Laser resurfacing in pigmented skin Dermatol Surg 21 1035 1037
24. 2 laser and Er:YAG laser: a practical guide of the laser techniques for the Er:YAG laser Dermatol Surg 25 959 964
25. R Jordan C Cummins A Burls 2000 Laser resurfacing of the skin for the improvement of facial acne scarring: a systematic review of the evidence Br J Dermatol 142 413 423
26. EL Tanzi TS Alster 2002 Treatment of atrophic facial acne scars with a dual-mode Er:YAG laser Dermatol Surg 28 551 555
27. JT Jeong JH Park YC Kye 2003 Resurfacing of pitted facial acne scars using Er:YAG laser with ablation and coagulation mode Aesthetic Plast Surg 27 130 134
28. HG Gassner DA Sherris CC Otley 2000 Treatment of facial wounds with botulinum toxin A improves cosmetic outcome in primates Plast Reconstr Surg 105 1948 1953
29. HG Gassner DA Sherris 2003 Chemoimmobilization: improving predictability in the treatment of facial scars Plast Reconstr Surg 112 1464 1466
30. RE Fitzpatrick 1999 Treatment of inflamed hypertrophic scars using intralesional 5-FU Dermatol Surg 25 224 232
31. W Manuskiatti RE Fitzpatrick 2002 Treatment response of keloidal and hypertrophic sternotomy scars: comparison among intralesional corticosteroid, 5-fluorouracil, and 585-nm flashlamp-pumped pulsed-dye laser treatments Arch Dermatol 138 1149 1155
32. I Bodokh P Brun 1996 [Treatment of keloid with intralesional bleomycin] Ann Dermatol Venereol 123 791 794
33. A Espana T Solano E Quintanilla 2001 Bleomycin in the treatment of keloids and hypertrophic scars by multiple needle punctures Dermatol Surg 27 23 27
34. F D'Andrea S Brongo G Ferraro 2002 Prevention and treatment of keloids with intralesional verapamil Dermatology 204 60 62
35. GS Ashcroft J Dodsworth E van Boxtel 1997 Estrogen accelerates cutaneous wound healing associated with an increase in TGF-beta1 levels Nat Med 3 1209 1215
36. MF Cordeiro A Mead RR Ali 2003 Novel antisense oligonucleotides targeting TGF-beta inhibit in vivo scarring and improve surgical outcome Gene Ther 10 59 71
37. M Shah DM Foreman MWJ Ferguson 1995 Neutralisation of TGF-β1 and TGF-β2 or exogenous addition of TGF-β3 to cutaneous rat wounds reduces scarring J Cell Sci 108 985 1002
38. SR Rahban WL Garner 2003 Fibroproliferative scars Clin Plast Surg 30 77 89
39. S Younai LS Nichter T Wellisz 1994 Modulation of collagen synthesis by transforming growth factor-beta in keloid and hypertrophic scar fibroblasts Ann Plast Surg 33 148 151
40. S O'Kane MW Ferguson 1997 Transforming growth factor beta s and wound healing Int J Biochem Cell Biol 29 63 78
41. HH Steenfos 1994 Growth factors and wound healing Scand J Plast Reconstr Surg Hand Surg 28 95 105
42. DH Chou W Lee CA McCulloch 1996 TNF-alpha inactivation of collagen receptors: implications for fibroblast function and fibrosis J Immunol 156 4354 4362
43. MR Duncan B Berman 1989 Differential regulation of collagen, glycosaminoglycan, fibronectin, and collagenase activity production in cultured human adult dermal fibroblasts by interleukin 1-alpha and beta and tumor necrosis factor-alpha and beta J Invest Dermatol 92 699 706
44. K Rapala 1996 The effect of tumor necrosis factor-alpha on wound healing. An experimental study Ann Chir Gynaecol Suppl 211 1 53
45. JR LaDuca AA Gaspari 2001 Targeting tumor necrosis factor alpha. New drugs used to modulate inflammatory diseases Dermatol Clin 19 617 635
46. LA Fernandez J Twickler A Mead 1985 Neovascularization produced by angiotensin II J Lab Clin Med 105 141 145
47. Y Koibuchi WS Lee GH Gibbons 1993 Role of transforming growth factor-beta 1 in the cellular growth response to angiotensin II Hypertension 21 1046 1050
48. MJ Daemen DM Lombardi FT Bosman 1991 Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall Circ Res 68 450 456
49. W Schorb KM Conrad HA Singer 1995 Angiotensin II is a potent stimulator of MAP-kinase activity in neonatal rat cardiac fibroblasts J Mol Cell Cardiol 27 1151 1160
50. K Rodgers S Xiong J Felix 2001 Development of angiotensin (1-7) as an agent to accelerate dermal repair Wound Repair Regen 9 238 247
51. KE Rodgers T Espinoza J Felix 2003 Acceleration of healing, reduction of fibrotic scar, and normalization of tissue architecture by an angiotensin analogue, NorLeu3-A(17) Plast Reconstr Surg 111 1195 1206
52. WL Smith DL DeWitt RM Garavito 2000 Cyclooxygenases: structural, cellular, and molecular biology Annu Rev Biochem 69 145 182
53. TA Wilgus Y Vodovotz E Vittadini 2003 Reduction of scar formation in full-thickness wounds with topical celecoxib treatment Wound Repair Regen 11 25 34
54. EA Blomme KS Chinn MM Hardy 2003 Selective cyclooxygenase-2 inhibition does not affect the healing of cutaneous full-thickness incisional wounds in SKH-1 mice Br J Dermatol 148 211 223